What this Trial Is About

This research aims to identify and describe the specific and non-specific vocal cord lesions that cause voice problems (dysphonia) in patients with systemic autoimmune diseases. It focuses on conditions like rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, primary Sjogren disease, sarcoidosis, vasculitis, myositis, Still disease, and Sharp syndrome. The study also seeks to determine if there are delays in diagnosis and how these lesions are managed. The study reviews medical records of patients with systemic autoimmune diseases who experience dysphonia and have documented vocal cord or laryngeal lesions. It examines lesions such as "bamboo nodes," rheumatoid nodules, cricoarytenoid joint arthritis, granulomas, mucosal ulcerations, submucous edema, hematomas, and vocal cord palsy. Treatments may include vocal therapy, oral steroids, surgery, and managing contributing factors like tobacco use or acid reflux. Participants are identified through their medical records from January 2014 to December 2024. Researchers analyze the nature of the vocal cord lesions responsible for dysphonia, assess diagnosis delays, and describe therapeutic approaches. The study aims to better understand the risk factors and management of these lesions in systemic autoimmune disease patients, contributing valuable information to improve care.

Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)